Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n = 30) were randomized to ANA 20 mg/day, 150 mg/day, or placebo for 2...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Krauss, Ronald M., Wojnooski, Kathleen, Orr, Joseph, Geaney, J. Casey, Pinto, Cathy Anne, Liu, Yang, Wagner, John A., Luk, Julie Mabalot, Johnson-Levonas, Amy O., Anderson, Matt S., Dansky, Hayes M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The American Society for Biochemistry and Molecular Biology 2012
Onderwerpen:
Patient-Oriented and Epidemiological Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276477/
https://ncbi.nlm.nih.gov/pubmed/22180633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M018010
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items